Literature DB >> 17972581

[Studies on chemical constituents of rhizomes of Ligusticum chuanxiong].

Xin-liang Chang1, Yun-bao Ma, Xue-mei Zhang, Zhi-yong Jiang, Ji-jun Chen.   

Abstract

OBJECTIVE: To study chemical constitutents of the rhizomes of Ligusticum chuanxiong.
METHOD: The rhizomes of L. chuanxiong were extracted with water to afford a water extract which was participated between H2O and EtOAc, n-BuOH, successively. The compounds were isolatedand purified by column chromatography from the EtOAc fraction, and identified based on spectral analyses. RESULT: Eleven compounds were isolated from the rhizomes of L. chuanxiong, and structures were characterized as (4S)-p-menth-1-ene4, 7-diol (1), aromadendrane-4alpha, 10beta-diol (2), aromadendrane-4beta, 10alpha-diol (3), aromadendrane-4beta, 10beta-diol (4), augustic acid (5), xiongterpene (6), pregnenolone (7), 3(R), 8(S), 9(Z)-falcarindiol (8), senkyunolide F (9), senkyunolide I (10), 4-hydroxyl-3-butylphthalide (11).
CONCLUSION: Compounds 1-5 were obtained from the rhizomes of L. chuanxiong for the first time.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17972581

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  4 in total

1.  Comparative pharmacokinetics of senkyunolide I in a rat model of migraine versus normal controls.

Authors:  Yi-Han Wang; Yan-Long Hong; Yi Feng; De-Sheng Xu; Shuang Liang; Xiao Lin; Lan Shen
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-02-10       Impact factor: 2.441

2.  Eremophilane derivatives from Senecio dianthus.

Authors:  Shuai Huang; Xian-li Zhou; Hong-yan Wang; Cui-juan Wang; Xiao-li Zhou; Feng Xiao; Jie Weng
Journal:  J Nat Med       Date:  2012-11-29       Impact factor: 2.343

3.  Exploring the Potential Mechanism of Chuanxiong Rhizoma Treatment for Migraine Based on Systems Pharmacology.

Authors:  Xianhua Wen; Yuncheng Gu; Beili Chen; Feipeng Gong; Wenting Wu; Hengli Tong; Qianfeng Gong; Songhong Yang; Lingyun Zhong; Xuping Liu
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-28       Impact factor: 2.629

Review 4.  Regulatory mechanisms of tetramethylpyrazine on central nervous system diseases: A review.

Authors:  Yue Liu; Guang Yang; Wenqiang Cui; Yunling Zhang; Xiao Liang
Journal:  Front Pharmacol       Date:  2022-09-05       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.